Trimodal treatment for localized high risk prostate cancer: A design of a phase II, multi-center, open-label, randomized, parallel-group study to compare the effectiveness and safety of radical prostatectomy, external beam radiotherapy (EBRT) and androgen deprivation therapy (ADT) versus EBRT and ADT for patients with localized high risk prostate cancer. PPCR [Internet]. 2020 May 21 [cited 2024 Dec. 4];6(1):3-8. Available from: https://journal.ppcr.org/index.php/ppcrjournal/article/view/94